Proterro
Proterro is a technology company.
Financial History
Proterro has raised $4.0M across 1 funding round.
Frequently Asked Questions
How much funding has Proterro raised?
Proterro has raised $4.0M in total across 1 funding round.
Proterro is a technology company.
Proterro has raised $4.0M across 1 funding round.
Proterro has raised $4.0M in total across 1 funding round.
Proterro is a biotechnology company founded in 2008 that develops a patented two-step technology platform using modified cyanobacteria to convert waste CO2 into high-value products like fermentable sugars for the food, feed, and energy industries.[1][2][4][5] It serves market leaders in these sectors through license agreements, producing tailored molecules in a unique solid-state bioreactor that enables high yields, low inputs, efficient land use, and modular scalability.[1][3] The platform solves the problem of resource constraints by creating cost-competitive products from waste CO2, reducing environmental impact while supporting partners' growth in a population-driven world.[1][2]
Proterro was established in 2008 as a venture-capital-backed biotech firm, initially focusing on algal products via patented photobioreactor technology.[2][4][5] The company is led by CEO Colin R. South, PhD, a biotechnology veteran with over 25 years of experience, including C-level roles at renewable firms like Mascoma, Lignol, and Novogy; he holds a PhD in Bio-process Engineering from Dartmouth and is an inventor on over 15 patent families.[2] Early development centered on a unique bioreactor using transgenic cyanobacteria to secrete fermentable sugars, with pivotal milestones including a patent for the photobioreactor and production of low-cost sugars for biofuels and other applications.[4][5][7] Operations include a plant in Orlando, Florida, with past headquarters in Bronxville, New York, and current ties to Princeton, New Jersey.[1][2]
Proterro rides the wave of sustainable biotech and circular economy trends, capitalizing on global demands for carbon capture, biofuels, and alternative proteins amid climate pressures and resource scarcity.[1][2][6] Timing aligns with rising CO2 regulations, biofuel mandates, and food security challenges, where its cyanobacteria-based system provides a low-cost edge over crop-based sugars or algae rivals.[4][5][7] Market forces like energy transitions and waste valorization favor it, as partners in food/feed/energy scale green products; Proterro influences the ecosystem by enabling faster commercialization of bio-based alternatives, reducing reliance on finite resources.[1][6]
Proterro is positioned for expansion through new partner licenses and bioreactor deployments, potentially targeting high-value food additives or advanced biofuels as CO2 capture incentives grow.[1][3] Trends like synthetic biology advancements and net-zero policies will accelerate adoption, though scaling production and regulatory hurdles could shape progress. Its influence may evolve by powering a new generation of circular bio-manufacturing, turning waste into staples for a constrained planet—echoing its core mission to nourish growth sustainably.[1][2]
Proterro has raised $4.0M in total across 1 funding round.
Proterro's investors include Cultivian Sandbox Ventures.
Proterro has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in November 2012.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2012 | $4.0M Series A | Cultivian Sandbox Ventures |